Serena Vittorio

发表

An integrated metabolomic and proteomic approach for the identification of covalent inhibitors of the main protease (Mpro) of SARS-COV-2 from crude natural extracts

G. Aldini, G. Vistoli, A. Altomare, 2022, Talanta.

Discovery of Neuroprotective Agents Based on a 5-(4-Pyridinyl)-1,2,4-triazole Scaffold

S. Cuzzocrea, S. Ventura, R. Di Paola, 2022, ACS chemical neuroscience.

Rational design of small molecules able to inhibit α-synuclein amyloid aggregation for the treatment of Parkinson’s disease

S. Ventura, S. Vittorio, R. Gitto, 2020, Journal of enzyme inhibition and medicinal chemistry.

Exploiting the 1-(4-fluorobenzyl)piperazine fragment for the development of novel tyrosinase inhibitors as anti-melanogenic agents: Design, synthesis, structural insights and biological profile.

A. Fishman, A. Fais, Sonia Floris, 2019, European journal of medicinal chemistry.

Vitamin D: a steroid hormone with progesterone-like activity.

S. Vittorio, V. Unfer, G. Monastra, 2018, European review for medical and pharmacological sciences.

Heterocyclic Compounds as Synthetic Tyrosinase Inhibitors: Recent Advances

S. Vittorio, Laura Ielo, Christian Dank, 2023, International journal of molecular sciences.

Exploring Molecular Contacts of MUC1 at CIN85 Binding Interface to Address Future Drug Design Efforts

Maria Rita Gulotta, Ugo Perricone, R. Gitto, 2021, International journal of molecular sciences.

Investigation on Hydrazonobenzenesulfonamides as Human Carbonic Anhydrase I, II, IX and XII Inhibitors

C. Supuran, G. Balboni, A. Angeli, 2022, Molecules.

4‐Fluorobenzylpiperazine‐Containing Derivatives as Efficient Inhibitors of Mushroom Tyrosinase

A. Fais, Sonia Floris, S. Vittorio, 2020, ChemMedChem.

Interaction of Aggregated Cationic Porphyrins with Human Serum Albumin

S. Vittorio, L. De Luca, A. Romeo, 2023, International journal of molecular sciences.

Ligand-Based Discovery of a Small Molecule as Inhibitor of α-Synuclein Amyloid Formation

S. Ventura, R. Gitto, L. De Luca, 2022, International Journal of Molecular Sciences.

Ensemble of structure and ligand-based classification models for hERG liability profiling

F. Lunghini, G. Vistoli, A. Pedretti, 2023, Frontiers in Pharmacology.

Synthesis, molecular docking and antibacterial activity of an oxadiazole-based lipoteichoic acid inhibitor and its metabolites

I. Fallis, Chiara Morozzi, S. Vittorio, 2023, Journal of molecular structure.

Computational Insights into the Sequence-Activity Relationships of the NGF(1–14) Peptide by Molecular Dynamics Simulations

G. Vistoli, A. Pedretti, S. Vittorio, 2022, Cells.